(919) 321-9017


Whitsell Innovations, Inc. presenting at the DIA Medical Affairs and Scientific Communications 2018 Annual Forum

FOR IMMEDIATE RELEASE:

Whitsell Innovations, Inc. presenting at the DIA Medical Affairs and Scientific Communications 2018 Annual Forum.

Robin Whitsell, Founder and President of Whitsell Innovations (WI), Inc., and Ann Winter-Vann, PhD, Senior Writer and Manager Medical Writing, will present at the Medical Affairs and Scientific Communications (MASC) 2018 Annual Forum March 19 - 21, 2018, in Rancho Mirage, California. This forum is sponsored by the Drug Information Association (DIA) and comprises workshops specifically designed to meet the needs of individuals in all branches of life science medical communications.

On Tuesday, March 20, in a morning Session, Ms. Whitsell is the Session Chair for a panel discussion entitled “Contemplate Your Template: New or Used Options for Protocol Development.” Together with TK Booker Porter, PhD (Senior Manager Global Regulatory Writing, Protocol Authoring Lead, Amgen, Inc.) and Amy Holbrook, MS (Director of Medical Writing, Keryz Biopharmaceuticals), Ms Whitsell will introduce the newly-issued TransCelerate Biopharma Common Protocol Template (CPT) and the NIH-FDA template with a discussion on the benefits and limitations of each template. In an afternoon Session, Ms Whitsell is Session Chair for a panel discussion entitled “Interstellar: Crossing the Galaxy Between Pharma and Medical Devices/Companion Diagnostics.” Together with Cyndi Carr, PhD (Senior Manager, Medical Writing, Ventana Medical Systems, Inc,. A Member of the Roche Group) and Ryan Hietpas, PhD (Consultant, Global Scientific Communications, Eli Lilly and Company), the audience will gain an overview of the regulations surrounding medical devices and companion diagnostics, steps for bringing medical devices to the market, practical knowledge in writing the associated documents. Dr. Carr will introduce “IVD Companion Diagnostics – A ‘Sirius’ly Bright Star”, and Dr. Hietpas will introduce “Device Classification and Investigational Device Exemptions – Following the Laws of the Universe.”

“This is always an extremely informative meeting,” says Ms. Whitsell. "The sessions this year are focused on best practices in the evolving regulatory and publication environments." On Tuesday, March 20, in an afternoon Session, Dr. Winter-Vann is the Session Chair for a panel discussion entitled “Secrets of the Editorial Office.” In this session, Jan Higgins, PhD (Managing Editor, Genetics in Medicine, American College of Medical Genetics and Genomics) and Elizabeth Blalock, MA (Managing Editor, Journal of Investigative Dermatology Society for Investigative Dermatology) will discuss why editorial offices insist on specific requests and why different journals ask for quite different styles. Participants will learn how to make improve their manuscripts writing and submissions, creating a better chance their articles will be reviewed and strongly considered.

On Wednesday, March 21, in a morning Session, Dr. Winter-Vann is Session Co-Chair with Michael Church, MA (Senior Director, Medical Writing, Syneos Health) and will present “Managing Up, Down, and Across: Effective Medical Writing Management Strategies and Business Practices.” Together with Cynthia Hooper, MA (Advisor, Biometrics Business Management and Advanced Analytics, Eli Lilly and Company), Carri Taylor, MBA (Associate Director, Medical Writing, inVentive Health), Holly Zoog, PhD, ELS (Executive Director, Medical Writing, Ultragenyx Pharmaceuticals, Inc.), and Matthew Robillard, MBA (Senior Director, Regulatory Strategic Writing, AbbVie, Inc.) this session will tackle the issues of running an effective medical writing business through a panel discussion with leaders and managers from a variety of backgrounds and companies and will provide a forum for associates and managers in medical writing to ask questions and exchange information to improve business practices.

DIA is a nonprofit, global, professional association of nearly 18,000 members who work in every facet of the discovery, development, and life cycle management of pharmaceuticals, medical devices, and related products. DIA is committed to the broad dissemination of information among its members, with continuously improved professional practice as the goal. DIA serves its members in a neutral, global environment that operates independent of the influence of any one organization or authority.

ABOUT WHITSELL INNOVATIONS, INC.

WI is a WBENC-certified woman owned full-service medical and scientific writing company headquartered in Chapel Hill, North Carolina.

Contact: info@whitsellinnovations.com
Website: www.whitsellinnovations.com

This release contains certain forward-looking statements which involve known and unknown risks, delays, uncertainties and other factors not under the company’s control. Whitsell Innovations, Inc.’s actual results, performance, or achievements could be materially different from those projected by these forward-looking statements. Given these risks and uncertainties, you are cautioned not to place undue reliance on the forward-looking statements.

###